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Abstract
Schistosoma japonicum is a major infectious agent of schistosomiasis. It has been reported that large number of proteins
excreted and secreted by S. japonicum during its life cycle are important for its infection and survival in definitive hosts.
These proteins can be used as ideal candidates for vaccines or drug targets. In this work, we analyzed the protein sequences
of S. japonicum and found that compared with other proteins in S. japonicum, excretory/secretory (ES) proteins are generally
longer, more likely to be stable and enzyme, more likely to contain immune-related binding peptides and more likely to be
involved in regulation and metabolism processes. Based on the sequence difference between ES and non-ES proteins, we
trained a support vector machine (SVM) with much higher accuracy than existing approaches. Using this SVM, we identified
191 new ES proteins in S. japonicum, and further predicted 7 potential interactions between these ES proteins and human
immune proteins. Our results are useful to understand the pathogenesis of schistosomiasis and can serve as a new resource
for vaccine or drug targets discovery for anti-schistosome.
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Introduction
Schistosoma japonicum (S. japonicum) is one of the major causative
agents of schistosomiasis, a tropical parasitic disease that infects
more than 200 million people in over 70 countries, and endangers
a further 650 million people worldwide [1]. During the life cycle of
S.japonicum, it is exposed to diverse environmental conditions and
changes from an asexual form in the intermediate hosts such as
snails to a sexual form in vascular system of the definitive host such
as human. It has been reported that large number of proteins
excreted or secreted by schistosomas are important for their
survival in their hosts [2].
To get through secretory pathways and anchor on the surface of
schistosoma, excretory/secretory (ES) proteins (including tegu-
ment proteins that are exposed to the host) usually possess certain
sequence features. When exposed to host tissues, these proteins not
only can stimulate the innate immune system, but also modulate
various host immune responses, thus help the pathogen evade the
host immune defence and protect them from oxidative stress [2].
For example, the protein lysophosphatidylserine in schistosomes can
stimulate dendritic cells via Toll-like receptor 2 (TLR2) to promote
Th2 immune response and regulate T cell development [3].
Therefore, identification of S.japonicum ES proteins is important for
both understanding parasite host interaction and finding new
candidate vaccines, drug targets or diagnostic reagents.
Using mass spectrometry hundreds of ES proteins have been
identified in different developmental stages of S.mansoni [4,5,6,7,8] and
S.japonicum [9,10,11]. Despite of that, the number of proteins already
found is still very limited due to the capacity of mass spectrometry and
in vitro culture. Therefore, tools like SignalP [12] and SecretomeP [13]
are frequently used to decide whether a protein is secretory. However,
these tools are specifically designed for secreted proteins in mammal or
bacteria, and may not perform the best in parasite.
In this paper, we compared the sequence features between
S.japonicum ES proteins collected from literatures [9,10,11] (167
proteins, denoted as SjSPs) and background proteins created from
NCBI non-redundant protein database (1401 proteins, denoted as
SjBgPs) to find out the specific features belonged to ES proteins.
Then based on the features of ES and non-ES proteins we trained
a SVM model with much higher accuracy than existing
approaches. Using this SVM model, we identified 191 new ES
proteins in S.japonicum, and further analyzed their potential
interactions with human immune proteins.
Results
Comparison between ES proteins and others
Simple sequence features. Compared with SjBgPs, SjSPs
tend to have more amino acid A, D, E, G, K and V but less N, C,
H, I, L, F, S and Y (P-value ,0.01, Fig. 1). Among the nine
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percentage of charged, acidic amino acids and lower percentage
of aliphatic and aromatic amino acids than SjBgPs (P-value ,0.01,
Fig. 2). Besides, SjSPs have more amino acid number, more
percent of negative (Asp+Glu) and positive amino acids (Arg+Lys),
and smaller average residue weight (P-value ,0.01, Fig. 3). SjSPs
are more stable than SjBgPs as instability index which is used to
estimate the stability of protein in a test tube of SjSPs is smaller
than that of SjBgPs (P-value=1.16e208) and 53.3% of SjSPs are
predicted as stable comparing to 37.3% of SjBgPs (P-
value=2.59e26). Detailed comparison of all primary sequence
features between SjSPs and SjBgPs are shown in Table S1.
Post-transcriptional modifications. SjSPs and SjBgPs
have no difference between the percent of proteins that have C-
mannosylation sites, N-linked glycosylation sites and O-GalNAc
glycosylation sites (P-value .0.01, Fig. 4) but higher percent of
proteins that have Ser (99.4% vs. 96.4%, P-value=1.55e203),
Thr (96.4% vs. 83.4%, P-value=6.34e209) and Tyr
phosphorylation sites (88.6% vs. 80.3%, P-value=8.18e204). As
to the number of these sites for each protein, SjSPs also have more
Ser, Thr and Tyr phosphorylation sites than SjBgPs (P-
value=1.56e205, 8.90e214, 4.90e208 respectively). Detailed
comparison can be found in Table S2.
Secondary structures. Compared with SjBgPs, SjSPs have
higher percentage of helix and coils (P-value=5.84e211 and
1.64e203), and lower percentage of turns (P-value=1.19e206,
Fig. 5). In the result of TMHMM’s prediction, only 6.00%
proteins of SjSPs have transmembrane regions, but 18.5% in
SjBgPs (P-value=8.22e207). Detailed comparison can be found
in Table S3.
Immune peptides. SjSPs and SjBgPs have similar percent of
the proteins that have weak, strong binding peptides of MHC I, II
alleles, linear B-cell epitopes and human proteasome cleave sites
except the Cytotoxic T lymphocyte (CTL) epitopes (98.2% vs.
74.4%, P-value ,0.01). Then, as to the number of each kind of
immune peptide for each protein, we found that SjSPs had more
number of weak binding peptides of MHC I and MHC II alleles
(P-value=4.78e203 and 1.90e216), more number of strong
binding peptides of MHC II alleles (P-value=1.76e212), more
linear B-cell epitopes (P-value=1.01e212), CTL epitopes (P-
value=1.07e206) and human proteasome cleave sites (P-
value=2.60e218) than SjBgPs (Fig. 6). These properties are
consistent with ES proteins’ function in immune evasion during
schistosomiasis. Detailed comparison can be found in Table S4.
Signal peptides. Similar percentage of SjSPs and SjBgPs
have at least one mitochondrial targeting peptide (13.8% vs.
12.4% in SjBgPs), but fewer proteins in SjSPs possess secretory
pathway signal peptide (11.4% vs. 17.3%, P-value=0.016). The
results are similar with the output of SecretomeP which predicts
66.7% of SjBgPs as secreted proteins while 52.7% of SjSPs (P-
value=4.58e205, Fig. 7). In summary, distinct from mammal and
bacteria only a limited number of schistosoma ES proteins contain
Figure 1. The average amino acid frequencies composition of SjSPs and SjBgPs.
doi:10.1371/journal.pone.0023786.g001
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Table S5.
Enzyme class. 81.4% of ES proteins are enzymes, while only
51.0% of SjBgPs are enzymes(P-value,0.01).Within these enzymes,
SjSPs contain more lyases (25.1% vs. 10.3%, P-value=6.85e210),
isomerase (12.0% vs. 4.64%, P-value=6.71e206) and ligase (12.6%
vs. 5.78%, P-value=8.71e205) than SjBgPs.
Domain class. 31 domains with two or more S.japonicum ES
proteins annotated are significantly enriched in SjSPs (P-value
,0.01, Table S6). Three of them are related with heat shock
protein 70 (IPR001023, IPR013126 and IPR018181), the
members of which respond to environmental stresses and may
be secreted to manipulate host’s immune response in
schistosomiasis [14]. Two domain are associated with
thioredoxin (IPR017936 and IPR012336), whose member such
as thioredoxin glutathione reductase was identified as protective
antigen and drug target in Schistosomes [15,16,17]. Besides, other
domains such as Dynein light chain (IPR001372) and calcium-
binding site (IPR018247 and IPR002048) were also found
significant in SjSPs. It has been reported that some proteins
similar with dynein light chain are expressed in tegument and act
as antigens in Schistosomes [18,19], and the calcium-binding
proteins were found to be secreted and function in host-parasite
interactions in Schistosomes [20,21].
GO class. 55 GO terms with three or more S.japonicum ES
proteins annotated are significantly enriched in SjSPs compared
with SjBgPs (P-value,0.01, see Table S7). Among them, 23 are
terms of biological processes; 14 are terms of cellular component
and 18 are terms of molecular function. In the terms of biological
process, most are associated with metabolic and physiological
process such as DNA metabolic process (GO:0006259),
dicarboxylic acid metabolic process (GO:0043648) and protein
metabolic process (GO:0019538). Other terms are associated with
regulation, development or stress response including regulation of
growth rate (GO:0040009), negative regulation of apoptosis
(GO:0043066), response to stimulus (GO:0050896) and response
to stress (GO:0006950) and so on. After penetrating host,
S.japonicum will transfer to schistosomula, and then develop into
a mature stage and ultimately produce eggs. SjSPs related to
metabolism, regulation and development may be important in
schistosoma’s maturation and response to host immune system.
Besides, SjSPs are also significantly enriched in GO terms
‘‘response to drug’’ and ‘‘response to salt stress’’, which might be
important in schistosoma’s fighting with drug or other stresses.
Predicting S.japonicum ES proteins
In the above discussion, we find that ES proteins of S.japonicum
do not necessarily contain secretory signal peptide and transmem-
brane regions, but they still have other sequence features different
from background proteins. In this section, we collected 126
S.japonicum nuclear and histone related proteins from NCBI non-
redundant proteins database as non-ES proteins of S.japonicum
Figure 2. The average percentage of nine physico-chemical classes of amino acids in SjSPs and SjBgPs.
doi:10.1371/journal.pone.0023786.g002
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the same number of proteins from SjnSPs, then divided them into
8 groups so that each group had 15 positive and 15 negative
proteins. For each SVM-based classifier, we left a group of
proteins to test the SVM accuracy and used the remaining positive
and negative proteins to train. Therefore, eight SVM-based
classifiers were generated in total. The average accuracies were
81.7% (sensitivity) and 84.2% (specificity) for positive and negative
dataset respectively. We defined that protein was predicted as ES
protein only when all eight SVM classifiers predicted it as ES
protein. By using the above strategy, the final precision to predict
ES proteins was 100% for 8 groups of tested proteins and the
Figure 3. Comparison of the distributions of other primary sequence features between SjSPs and SjBgPs. Gravy: Grand average of
hydropathicity. Extinction coefficient: an index indicates how much light a protein absorbs at a certain wavelength. Instability index: an estimateo f
the stability of your protein in a test tube.
doi:10.1371/journal.pone.0023786.g003
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methods: SignalP [12], SecretomeP [13], Phobius [22] and
ProtComp [23] (Table 1). Using our classifier, we identified 242
SjBgPs as potential ES proteins from SjBgPs (Table S8). Among
them, 51 (21.1%) proteins have already been reported as ES
proteins or locating in tegument of Schistosomes (Table S8). For
example, glutathione S-transferase (CAX72404.1) can stimulate anti-
fecundity immunity [24]. Thioredoxin peroxidase (|CAX75864.1), an
egg secretory product and antioxidant enzyme, is necessary for
schistosome to escape oxidative damage from host immune system
[25,26]. Another important protein is paramyosin (ACA62791.1)
which is released by schistosome cercariae while penetrating
human skin. It may function in immune evasion and immune
response during infection [27,28]. Furthermore, tetraspanin
(CAX70119.1) expresses in the tegument and functions in the
host immune response and invasion. It was suggested that
tetraspanin might interact with host ligand such as MHC and
was considered as a candidate vaccine for schistosome [29,30].
Fatty acid binding protein 7 (CAX77287.1) is secreted by adult
S.japonicum and plays an important role in the uptake and transport
of host-derived fatty acids for the schistosomes lacking the system
of fatty acids synthesis [10]. In addition, superoxide dismutase
(CAX71766.1) is also reported as ES protein [21]. All these facts
suggest the accuracy of our SVM classifier.
Predict host-schistosoma japonicum interaction
Proteins secreted by S.japonicum were considered to be involved
in host-parasite interaction [9]. In our analysis, 7 interactions
between 4 ES proteins of S.japonicum and 7 human immune
proteins were identified following the pipeline described in
Methods (Table S9 and Fig. 8). Among the 4 ES proteins,
SJCHGC07797 protein (AAX30806.1)has the largest number of
interacting partners (4 proteins, Fig. 8). One of the partners, called
neural cell adhesion molecule 1 (NCAM1), is involve in the expansion of
T cells and dendritic cells which play an important role in immune
surveillance in human. Neural cell adhesion molecule was found to be
upregulated in Chagas’ disease myocarditis which caused by the
Trypanosoma cruzi (T. cruzi) parasite and considered as a receptor for
tissue targeting and cellular invasion by T. cruzi in Chagas’ disease
[31]. Another partner named platelet-derived growth factor
receptor beta precursor (Pdgfrb) was upregulated in liver of human
infected by Clonorchis sinensis [32]. Another ES protein Thioredoxin
peroxidise was predicted to interact with peroxiredoxin 6 (PRDX6),
which is important for host defence against Opisthorchis viverrini
Figure 4. The distributions of all post-modification features of SjSPs and SjBgPs. NetCGlyc: C-mannosylation sites. NetNGlyc: N-linked
glycosylation sites. NetOGlyc: O-GalNAc (mucin type) glycosylation sites. NetPhos_Ser: Ser phosphorylation sites. NetPhos_Thr: Thr phosphorylation
sites. NetPhos_Tyr: Tyr phosphorylation sites.
doi:10.1371/journal.pone.0023786.g004
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associated with parasite interaction while other parasites infected,
suggesting the similar function against to S.japanicum.
Discussion
Compared with other proteins, ES proteins are generally longer,
more likely to be stable and enzyme, more likely to contain
immune-related binding peptides and more likely to be involved in
regulation and metabolism processes. However, only a limited
number of schistosoma ES proteins contain signal peptides,
leading to the failure of popular prediction tools e.g. SignalP. In
this paper, we combined 1,067 sequence features and designed a
SVM-based classifier to distinguish ES proteins from other
proteins of S.japonicum. Using this SVM, we identified 242 potential
ES proteins, among which 51 are known previously. According to
the prediction, the ES proteins are taken up 17.3% of the whole
protein set for prediction. The relatively high percentage of ES
proteins in S.japonicum suggests the importance of them in
schistosoma infection.
Long term survival of schistosomes relies on their interactions
with their host, which resulting in the escape of immune response
and induction of immunological tolerance. ES proteins may mimic
host proteins and directly or indirectly to modulate host immune
response [34]. However, the molecular mechanisms involved in
the host-parasite interactions are still poorly understood. We
further identified 7 potential interactions between ES proteins and
human immune proteins based on DDI and sequence similarity.
These interactions may help reveal the pathogenesis of schistoso-
miasis and find out new vaccines and drug targets.
Materials and Methods
Dataset
We collected excretory/secretory proteins of S.japonicum includ-
ing tegument proteins that are exposed to the host from public
literatures [9,10,11], denoted as SjSPs. As control, we randomly
selected 2,411 proteins (about 10%) out of all NCBI-recorded
S.japonicum proteins as background, denoted as SjBgPs. We used
PISCES [35] to remove proteins with sequences identity over 20%
in each dataset. Then, to obtain the dataset of SjSPs more
accurately, we further filtered the ES proteins with expression level
in hepatic schistosomulum, adult and egg lower than 1 [9]. Finally,
we got 167 SjSPs and 1,401 SjBgPs. To get a negative dataset for
SVM training, we collected the nuclear and histone related
proteins from NCBI non-redundant database and also remove
proteins with sequences identity over 20% by PISCES [35],
resulting in 126 negative proteins (non-ES, denoted as SjnSPs).
Sequence features of proteins
Primary sequence features. Pepstats [36] was used to
calculate average residue weight, isoelectric point, probability of
protein expression in E. coli inclusion bodies, extinction coefficient
at 1 mg/ml (A280) and 9 physico-chemical classes of amino acids
Figure 5. The average composition of secondary structures of SjSPs and SjBgPs.
doi:10.1371/journal.pone.0023786.g005
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and V); aromatic (F, H, W and Y); non-polar (A, C, F, G, I, L, M,
P, V, W and Y); polar (D, E, H, K, N, Q, R, S, T and Z), charged
(B, D, E, H, K, R, Z), aliphatic (A, I, L, V) and basic (H, K, and
R). ProtParam [37] were used to calculate the basic parameters
including the composition of each amino acid, total number of
amino acid, molecular weight, percent of negatively or positively
charged residues, estimated half-life and instability index.
Structure properties. The percentage of four secondary
structure types (alpha helix, beta sheet, turns and coil) were
calculated using garnier [38]. TMHMM [39,40] was used to
predict the number of transmembrane helical regions.
Figure 6. The distributions of all immune peptide features of SjSPs and SjBgPs. BepiPred: linear B-cell peptides. NetChop: Human
proteasome cleave sites.
doi:10.1371/journal.pone.0023786.g006
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key role in immune response, we counted the number of several
immunology peptides including MHC class I weak and strong
peptides [41], MHC class II weak and strong peptides, linear B-
cell peptides [42], human proteasome cleave sites [43] and
cytotoxic T-lymphocyte epitope (CTL) epitopes [44] using tools
listed in Table S10.
Target and signal sites. Mitochondria target sites [45],
export nuclear target sites [46], signal peptide cleavage sites [12]
and secreted signal sites [13] were predicted using tools listed in
Table S11.
Post-translational modification. We analyzed several post-
translational modifications i.e. C-mannosylation, N-glycosylation
[47], O-glycosylation [48], N-terminal acetylation sites and Try,
Thr, Ser phosphorylation sites [49] using tools listed in Table S12.
Enzyme classes. ProtFun [50] was used to predict whether a
protein is an enzyme, and which category (oxidoreductase,
transferase, hydrolase, lyase, isomerase and ligase) it belongs to.
Domain analysis of proteins. Domain information of each
protein was parsed using InterProScan [51], a web server that
combines multiple methods to search against InterPro database
through sequence similarity.
Gene Ontology. The GO of SjSPs, SjnSPs and SjBgPs were
annotated using Blast2GO with default parameter settings [52].
Statistical test. Sided t test was used to evaluate the
difference between the means of each feature with continue
value, while for the features with boolean values, hypergeometric
test was used to evaluate whether the proteins with the feature are
significantly enriched or less in SjSPs compared with SjBgPs.
Figure 7. The percentage of all signal peptides in SjSPs and SjBgPs. SignalP: secretory pathway signal peptide predicted by SignalP program.
Mitochondria: mitochondrial target sites. Nuclear: export nuclear target sites. Secretory: secreted via non-classical secretory pathway.
doi:10.1371/journal.pone.0023786.g007
Table 1. Comparsion of prediction accuracy for ES proteins of
Schistosoma japonicum.
Phobius ProtComp SecretomP SignalP SVM
precision 77.8% 52.0% 52.7% 76.0% 100%
recall 8.40% 7.80% 52.7% 11.4% 81.7%
The precision and recall of Phobius, ProtComp, SecretomP and SignalP are
evaluated by the dataset of SjSPs and SjnSPs. The performance of SVM is
evaluated by the eight groups of tested proteins.
doi:10.1371/journal.pone.0023786.t001
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The basic concept of SVM is to transform the input vectors to a
higher dimensional space through kernel functions, and then a
hyperplane that maximizes the margin between positive and
negative samples is found [53]. The SVM for ES protein
classification depends on the selection of kernel function. Because
of its localized and finite responses across the entire range of the
real x-axis, radial basis function (RBF) is by far the most popular
choice of kernel used in SVM. In this study, we also used SVM
with RBF kernel to train features of ES proteins.
167 SjSPs and 126 SjnSPs were used as positive and negative
dataset respectively in the training. After removing features that
are missed in over 10% of the proteins, 1,067 sequence features
were used to train the SVM. All features are scaled across training
and testing samples to zero mean and unit variance. The objective
is to avoid features in greater numeric ranges dominate those in
smaller numeric ranges.
We randomly selected 120 proteins from 167 positives and
other 120 proteins from 126 negatives. Then we divided these
proteins into 8 groups so that each group had 15 positive and
negative proteins. For each SVM classifier, we left a group of
proteins to test the SVM accuracy and used the remaining positive
and negative proteins to train. To find the best model, we searched
through a large range of the cost parameter and gamma
parameter in RBF kernel with 10-fold cross validation. In total,
eight SVM classifiers were generated. Finally, we predicted the
SjBgPs dataset by 8 classifiers and selected those proteins that were
predicted as ‘‘true’’ by all classifiers. The SVM training was done
by ‘‘e1071’’ R package.
Prediction of host-parasite interactions
We only considered host-parasite interactions between human
immune system related proteins and S.japonicum ES proteins. It has
been reported that schistosoma ES proteins may mimic human
protein with similar sequence or domains, and hence evade or
regulate immune response [54]. Therefore we made our
predictions based on protein domain-domain interaction (DDI)
and sequence similarity. More specifically, a human protein and a
S.japonicum ES protein is considered to interact with each other if i)
their domains could form at least one known DDI, ii) this ES
protein is similar to at least one known interacting partner of the
human protein. Our threshold of similarity is aligned length
.=30 and identity .=30% by BLAST. Human immune system
related proteins were downloaded from Immunome database[55]
and human protein-protein interactions from HPRD [56].
Besides, we collected the domain-domain interactions that are
inferred from PDB [57] from the DOMINE database [58], which
contains both interactions inferred from PDB and predicted from
different computational approaches.
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